Related Experiment Video
Updated: Feb 2, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Atrial Fibrillation and Heart Failure: Untangling a Modern Gordian Knot
Allan C Skanes1, Anthony S L Tang1
1London Heart Rhythm Program, Western University, London, Ontario, Canada.
Insights
Heart failure (HF) and atrial fibrillation (AF) often coexist, increasing mortality. Catheter ablation to restore sinus rhythm shows promise for improving HF symptoms and function, though long-term outcomes require further study.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Research
Background:
- Heart failure (HF) and atrial fibrillation (AF) are prevalent, especially in aging populations, with combined mortality significantly higher than individual conditions.
- A complex interplay exists between AF and HF, involving shared risk factors and intertwined pathophysiological mechanisms.
- Asymptomatic left ventricular dysfunction can worsen or be worsened by AF, leading to HF with reduced ejection fraction (HFrEF) or HF with preserved ejection fraction (HFpEF).
Purpose of the Study:
- To review the relationship between AF and HF, focusing on pathophysiology and treatment strategies.
- To evaluate the impact of restoring sinus rhythm on HF outcomes, particularly concerning catheter ablation versus pharmacological approaches.
Main Methods:
- Review of existing literature on the pathophysiology and management of coexisting AF and HF.
- Analysis of recent studies investigating the efficacy of catheter ablation for achieving sinus rhythm in HF patients.
- Comparison of outcomes between pharmacological rhythm control and catheter ablation in HF populations.
Main Results:
- Pharmacological restoration of sinus rhythm has not demonstrated significant improvements in cardiovascular or total mortality for HF patients.
- Recent studies suggest catheter ablation to achieve sinus rhythm may significantly improve symptoms, cardiac function, and potentially reduce mortality in HF patients.
- The long-term prognostic impact of catheter ablation on HF outcomes remains under investigation.
Conclusions:
- While traditional treatments have improved quality of life for HF patients, prognosis alteration remains limited.
- Catheter ablation for AF in HF patients presents a promising strategy for improving clinical outcomes and cardiac function.
- Further research is needed to definitively establish the long-term benefits and optimal role of catheter ablation in managing HF.
Abstract:
Heart failure (HF) and atrial fibrillation (AF) share common risk factors and frequently coexist. Both are highly prevalent in our aging population, and mortality associated with the combination is significantly higher than for each alone. An intricate link exists between AF and HF, including interrelated mechanisms and pathophysiology. Asymptomatic left ventricular systolic or diastolic dysfunction can exacerbate or be exacerbated by AF, resulting in HF with reduced ejection fraction or preserved ejection fraction. A number of treatment strategies have improved symptoms, exercise tolerance, and quality of life for patients with HF, but few have resulted in alteration in prognosis. Sinus rhythm, achieved pharmacologically, has not altered important outcomes, including cardiovascular or total mortality in patients with HF. In recent studies, catheter ablation to achieve sinus rhythm seems to have a significant impact on symptoms, heart function, and possibly mortality. Until future studies can confirm or clarify the impact of catheter ablation on outcomes, the field remains cautious but optimistic that better treatment strategies for patients with HF with reduced ejection fraction or preserved ejection fraction are within reach.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Heart Failure Drugs: Diuretics

